3Diab YA, Thomas A, Luban NL, et al. Acquired cytochrome C oxidase impairment in apheresis platelets during storage: a possible mechanism for depletion of metabolic adenosine tripbosphate [J]. Transfusion,2012,52(5): 1024-1030.
4Moroff G, Kurtz J, Seetharaman S, et al. Comparative in vitro evaluation of apheresis platelets stored with 100% plasma or 65%platelet additive solution Ⅲ/35% plasma and including periods without agitation under simulated shipping conditions [J]. Transfusion,2012,52(4):834-843.
5Lozano ML, Rivera J, Vicente V. Platelet concentrates from whole-blood donations (buffy-coat) or aphaeresis: which one to use? [J]. Medicina Clinica,2012,138(12):528-533.
6Skripchenko A, Myrup A, Awatefe H. A rest period before agitation may improve some in vitro aphaeresis platelet parameters during storage [J]. Transfusion,2012,52(7):1433-1438.
7温柏平,杨跃煌.血细胞分离机原理与临床应用[M].北京:人民卫生出版社.2007:9-10.
8Ali SF. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods [J]. Transfus Apher Sci,2011,44(1): 11-13.
9全血成分血质量要求[S].中华人民共和国国家标准,GB18469-2001.
10Rank A, Nieuwland R, Crispin A, et al. Clearance of platelet microparticles in vivo[J]. Platelets,2011,22(2): 111 - 116.
